CN106235329A - 一种治疗代谢综合症的功能性食品及其制备方法 - Google Patents
一种治疗代谢综合症的功能性食品及其制备方法 Download PDFInfo
- Publication number
- CN106235329A CN106235329A CN201610608080.8A CN201610608080A CN106235329A CN 106235329 A CN106235329 A CN 106235329A CN 201610608080 A CN201610608080 A CN 201610608080A CN 106235329 A CN106235329 A CN 106235329A
- Authority
- CN
- China
- Prior art keywords
- parts
- metabolic syndrome
- functional food
- xeraphium
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title claims abstract description 27
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title claims abstract description 27
- 235000013376 functional food Nutrition 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 210000000582 semen Anatomy 0.000 claims abstract description 23
- 238000000605 extraction Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 13
- 102000008186 Collagen Human genes 0.000 claims abstract description 12
- 108010035532 Collagen Proteins 0.000 claims abstract description 12
- 240000005175 Turpinia pomifera Species 0.000 claims abstract description 12
- 229920001436 collagen Polymers 0.000 claims abstract description 12
- 235000013312 flour Nutrition 0.000 claims abstract description 12
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 4
- 150000002333 glycines Chemical class 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 238000011552 rat model Methods 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 241000700159 Rattus Species 0.000 description 10
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000007683 Pediatric Obesity Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种治疗代谢综合症的功能性食品及其制备方法,由绿豆粉、面粉、海洋胶原肽、山香圆、鱼腥草、桔梗和莱菔子制备而成,先将山香圆和莱菔子进行煎煮、醇提、过滤、干燥、粉碎;再将鱼腥草和桔梗进行煎煮、醇提、过滤、干燥和粉碎;然后与绿豆粉、面粉、海洋胶原肽以及水混合揉搓成面团,干燥即可。通过动物试验研究发现,本发明涉及的功能性食品在辅助治疗代谢综合症模型大鼠方面具有显著的效果。本发明涉功能性食品可以实现内脏脂肪积聚的改善,有效预防或辅助治疗代谢综合症。
Description
技术领域
本发明涉及食品保健领域,具体是一种治疗代谢综合症的功能性食品及其制备方法。
背景技术
体重超标或过度肥胖,并伴有高血压、高血脂、高血糖、动脉粥样硬化和高胰岛素血症等一系列病变,这种现象在医学上被称为代谢综合症。代谢综合症是城市人口面临的一种常见身体问题,它不仅可以增加糖尿病和心脑血管疾病的发病危险,同时也增加心脑血管疾病的死亡率。代谢综合症是一个多基因的,遗传性的疾病,而且受环境的影响。其临床特点是肥胖、血脂异常、高血糖和高血压四方面合并出现。代谢综合症以前在我国发病情况并不多见,因为那时的生活水平并不高,随着生活水平的不断提高,据不完全统计,我国现在己有肥胖病人700万人,特别是青少年肥胖的越来越多。高血压病人在我国大概有1.6亿人,糖尿病病人大概有3-4千万,所以代谢综合症的病人在我国的发病情况目前也很高。另据中华医学会糖尿病学会的调查,目前在中国城市20岁以上的人群中,代谢综合症的患病率为14%-16%。代谢综合症随着年龄的增高而增加,在50-70岁人群中达到发病高峰,其中女性患者多于男性。
目前,对于代谢综合症的防治,主要从以下几个方面进行:(1)进行有氧锻炼;(2)合理调整饮食结构,减少脂肪摄入;(3)保证正常体重;(4)药物治疗。一般来说,单独采用药物治疗的效果很有限,同时还伴有较强的副作用。因此,为了有效预防或治疗代谢综合症,人们开始注重药物治疗的同时辅以功能性食品,从而实现内脏脂肪积聚的改善。
发明内容
本发明的目的在于提供一种治疗代谢综合症的功能性食品及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种治疗代谢综合症的功能性食品,由以下重量份的原料制备而成:绿豆粉60~80份,面粉80~100份,海洋胶原肽4~6份,山香圆20~24份,鱼腥草24~28份,桔梗18~22份,莱菔子16~20份。
一种所述的治疗代谢综合症的功能性食品的制备方法,具体制备步骤如下:
(1)取山香圆和莱菔子,以13~15倍量水分别煎煮提取2~4次,每次1~2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50~80%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉A;
(2)取鱼腥草和桔梗,以10~12倍量水分别煎煮提取2~3次,每次1~2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50~60%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉B;
(3)将干燥粉A与干燥粉B混合,然后再与绿豆粉、面粉混合,将海洋胶原肽用水稀释6~8倍,然后加入上述的混合粉料中,搅拌揉搓成面团,放入100~110℃的干燥箱中进行干燥,即可。
与现有技术相比,本发明的有益效果是:
通过动物试验研究发现,本发明涉及的功能性食品在辅助治疗代谢综合症模型大鼠方面具有显著的效果。本发明涉功能性食品可以实现内脏脂肪积聚的改善,有效预防或辅助治疗代谢综合症。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
治疗代谢综合症的功能性食品,由以下重量份的原料制备而成:绿豆粉60份,面粉100份,海洋胶原肽4份,山香圆24份,鱼腥草24份,桔梗22份,莱菔子16份。
上述食品的制备步骤如下:
(1)取山香圆和莱菔子,以13倍量水分别煎煮提取2次,每次1h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉A;
(2)取鱼腥草和桔梗,以10倍量水分别煎煮提取2次,每次1h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉B;
(3)将干燥粉A与干燥粉B混合,然后再与绿豆粉、面粉混合,将海洋胶原肽用水稀释6倍,然后加入上述的混合粉料中,搅拌揉搓成面团,放入100℃的干燥箱中进行干燥,即可。
实施例2
治疗代谢综合症的功能性食品,由以下重量份的原料制备而成:绿豆粉70份,面粉90份,海洋胶原肽5份,山香圆22份,鱼腥草26份,桔梗20份,莱菔子18份。
上述食品的制备步骤如下:
(1)取山香圆和莱菔子,以14倍量水分别煎煮提取3次,每次1.5h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达65%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉A;
(2)取鱼腥草和桔梗,以11倍量水分别煎煮提取3次,每次1.5h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达55%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉B;
(3)将干燥粉A与干燥粉B混合,然后再与绿豆粉、面粉混合,将海洋胶原肽用水稀释7倍,然后加入上述的混合粉料中,搅拌揉搓成面团,放入105℃的干燥箱中进行干燥,即可。
实施例3
治疗代谢综合症的功能性食品,由以下重量份的原料制备而成:绿豆粉80份,面粉80份,海洋胶原肽6份,山香圆20份,鱼腥草28份,桔梗18份,莱菔子20份。
上述食品的制备步骤如下:
(1)取山香圆和莱菔子,以15倍量水分别煎煮提取4次,每次2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达80%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉A;
(2)取鱼腥草和桔梗,以12倍量水分别煎煮提取3次,每次2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达60%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉B;
(3)将干燥粉A与干燥粉B混合,然后再与绿豆粉、面粉混合,将海洋胶原肽用水稀释8倍,然后加入上述的混合粉料中,搅拌揉搓成面团,放入110℃的干燥箱中进行干燥,即可。
实施例4本发明的功能性营养食品对代谢综合症大鼠模型的影响
雄性Wistar大鼠,体重180-220g,动物首先进行筛选,以首次给予足底电击和噪声刺激时动物表现迅速的逃避、尖叫、竖尾、喘息并不易适应为标准,选为本研究动物。动物单独笼养于刺激笼中。开始刺激前首先正常饲养一周,然后以高脂饲料饲喂,并开始刺激,每口刺激2次,刺激强度:上、下午各2h,连续刺激约8周。造模结束后做糖耐量测定试验。口服糖耐量试验(OGTV):大鼠禁食12h后,以2.5g/kg剂量灌胃50%葡萄糖溶液,尾静脉取血检测2h的血糖值,淘汰血糖低于6. 20mmo1/L的大鼠,淘汰体重低于350g的大鼠,然后分组并给药。
将实施例2制备的功能食品粉剂通过加水润湿后制作成条状的鼠粮,并烘烤至干硬。将造模成功大鼠按照体重随机分为如下各组:模型对照组、提取物对照组、功能性食品组,每组15只,连续按照表1的方式饲喂10周。
表1造模后各组大鼠饲喂方式
按上述方式饲喂10周后,各组大鼠称重、测血压、糖耐量、血脂,统计结果见表2,表3、表4。
表2各组大鼠的体重和血压变化
*与模型对照组比较,P<0.05;**与提取物对照组较,P<0.05;
·与模型对照组比较,P<0.01;··二与提取物对照组比较,P<0.01。
表3各组大鼠的糖耐量变化
*与模型对照组比较,P<0.05;**与模型对照组比较,P<0.01;
·与提取物对照组较,P<0.05;··与提取物对照组比较,P<0.01。
表4各组大鼠的血脂变化
*与模型对照组比较,P<0.05;**与模型对照组比较,P<0.01;
·与提取物对照组较,P<0.05;··与提取物对照组比较,P<0.01。
通过表2、表3、表4的试验结果可以看出,本发明的功能性食品组大鼠的体重、收缩压、血糖和血脂都有显著降低,与模型对照组、提取物对照组比较,有显著性差异((P<0.05或极显著性差异((P<0.01),这说明本发明的功能性食品对代谢综合症大鼠模型均有很好的防治作用。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
Claims (2)
1.一种治疗代谢综合症的功能性食品,其特征在于,由以下重量份的原料制备而成:绿豆粉60~80份,面粉80~100份,海洋胶原肽4~6份,山香圆20~24份,鱼腥草24~28份,桔梗18~22份,莱菔子16~20份。
2.一种如权利要求1所述的治疗代谢综合症的功能性食品的制备方法,其特征在于,具体制备步骤如下:
(1)取山香圆和莱菔子,以13~15倍量水分别煎煮提取2~4次,每次1~2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50~80%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉A;
(2)取鱼腥草和桔梗,以10~12倍量水分别煎煮提取2~3次,每次1~2h,合并提取液,浓缩至65℃时相对密度为1.10~1.20,加入乙醇使含醇量的体积百分比达50~60%,静置沉淀,滤过,得醇沉液,干燥,粉碎成干浸膏粉,得干燥粉B;
(3)将干燥粉A与干燥粉B混合,然后再与绿豆粉、面粉混合,将海洋胶原肽用水稀释6~8倍,然后加入上述的混合粉料中,搅拌揉搓成面团,放入100~110℃的干燥箱中进行干燥,即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610608080.8A CN106235329A (zh) | 2016-07-29 | 2016-07-29 | 一种治疗代谢综合症的功能性食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610608080.8A CN106235329A (zh) | 2016-07-29 | 2016-07-29 | 一种治疗代谢综合症的功能性食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106235329A true CN106235329A (zh) | 2016-12-21 |
Family
ID=57603612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610608080.8A Pending CN106235329A (zh) | 2016-07-29 | 2016-07-29 | 一种治疗代谢综合症的功能性食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106235329A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1370409A (zh) * | 2001-02-21 | 2002-09-25 | 孙光华 | 掺加中草药和杂粮成分的食疗面粉系列 |
CN102406174A (zh) * | 2011-12-02 | 2012-04-11 | 安徽燕之坊食品有限公司 | 一种功能性食品组合物及应用 |
CN102987383A (zh) * | 2012-11-27 | 2013-03-27 | 上海交通大学 | 平衡肠道菌群结构改善代谢综合症的全营养组合物及应用 |
CN104435799A (zh) * | 2014-10-29 | 2015-03-25 | 杨洪银 | 一种治疗肾功能衰竭的中药冲剂及其检验方法 |
CN105079056A (zh) * | 2015-08-31 | 2015-11-25 | 伏广珍 | 治疗牙周炎的山香圆片及其制法与治疗代谢综合症的用途 |
-
2016
- 2016-07-29 CN CN201610608080.8A patent/CN106235329A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1370409A (zh) * | 2001-02-21 | 2002-09-25 | 孙光华 | 掺加中草药和杂粮成分的食疗面粉系列 |
CN102406174A (zh) * | 2011-12-02 | 2012-04-11 | 安徽燕之坊食品有限公司 | 一种功能性食品组合物及应用 |
CN102987383A (zh) * | 2012-11-27 | 2013-03-27 | 上海交通大学 | 平衡肠道菌群结构改善代谢综合症的全营养组合物及应用 |
CN104435799A (zh) * | 2014-10-29 | 2015-03-25 | 杨洪银 | 一种治疗肾功能衰竭的中药冲剂及其检验方法 |
CN105079056A (zh) * | 2015-08-31 | 2015-11-25 | 伏广珍 | 治疗牙周炎的山香圆片及其制法与治疗代谢综合症的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1301666C (zh) | 一种能增强免疫力的保健食品及其制备方法 | |
CN101032560A (zh) | 一种治疗睡眠障碍的中药组合物及制备方法 | |
CN105341641A (zh) | 一种降糖保健面粉及其制备方法 | |
CN102600212A (zh) | 一种增强免疫力、辅助治疗肿瘤的医药保健品 | |
CN104288412B (zh) | 一种治疗代谢综合征的中药组合物 | |
CN101491343A (zh) | 一种增强人体免疫力的保健品及其制备方法 | |
CN1471845A (zh) | 一种以灵芝、天麻为原料的保健食品及其制备方法 | |
CN106173605A (zh) | 一种包含葛根和石斛的降血糖保健组合物 | |
CN106798776A (zh) | 一种用于心悸、失眠的中成药及其制备工艺 | |
CN106235329A (zh) | 一种治疗代谢综合症的功能性食品及其制备方法 | |
CN102784163A (zh) | 一种食用菌类复合多糖养生保健治疗配方及其制备方法 | |
CN102406174B (zh) | 一种功能性食品组合物及应用 | |
CN1682814A (zh) | 一种治疗乙型肝炎的药物及其制备方法 | |
CN1679658A (zh) | 一种治疗艾兹病的中药制剂及其加工方法 | |
CN105055851A (zh) | 一种治疗糖尿病的中药组合物、其制剂及其应用 | |
CN104721192A (zh) | 一种包含氯卡色林的药物组合物及其医药用途 | |
CN103610991B (zh) | 用于治疗猪胃溃疡的药物及其制备方法 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN107412677B (zh) | 一种牛大力袋泡茶及其制备方法 | |
CN1257728C (zh) | 用于治疗糖尿病的中成药及其制备方法 | |
CN105749148A (zh) | 一种具有抗疲劳效果的中药组合提取物及其制备方法和应用 | |
CN106038845A (zh) | 一种治疗亚健康提高免疫力的药物组合物及其制备方法 | |
CN1931256A (zh) | 一种用于戒毒的中药胶囊制剂及其制备方法 | |
CN1742933A (zh) | 一种用于降血糖的药物及其制备方法 | |
CN1257721C (zh) | 一种治疗慢性肝病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161221 |